| |
|
|
|
HTG Molecular Diagnostics- Inc.  
|
|
3.3 -0.1 (-0.03%) |
08-17 16:00 |
|
Open: |
3.39 |
Pre close: |
3.4 |
Target:
|
4.42
|
|
High: |
3.4 |
Low: |
3.2 |
Resistance:
|
3.78
4.42
|
|
Volume: |
365,901 |
Market Cap: |
94M |
Support:
|
3.14
2.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.36
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
3.16 |
Signal(12,26,9): |
-0.01  |
|
MA(100): |
3.49 |
Stochastic Oscillator |
%K(14,3):
|
56.96 |
|
MA(250): |
3.12 |
%D(3): |
58.59 |
|
Average Volume(K) |
3-Month: |
43179
|
52-Week |
High:
|
5.83 |
|
10-Days: |
63423 |
Low: |
1.59 |
|
RSI |
RSI(14):
|
51.63 |
Change(%): |
62.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.970 |
Return on Equity (ttm) |
-130.8 |
Shares Out. (M) |
28.42 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-48.9 |
Shares Float (M) |
27.87 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.00 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
203.3 |
% Held by Institutions |
55.50 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.093 |
Shares Short (K) |
4250 |
|
Book Value (p.s.) |
3.290 |
EBITDA (p.s.) |
-0.168 |
P/E |
-3.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.00 |
|
Profit Margin |
-81.10 |
Operating Cash Flow
(M) |
-14.64 |
P/S |
78784032.00 |
|
Operating Margin |
-99.84 |
Levered Free Cash Flow
(M) |
-9.11 |
P/CF |
-6.41 |
|
|
|
|
|
|
